Biomarkers and cardiovascular risk assessment for primary prevention: an update.
about
Association of branched-chain amino acids with carotid intima-media thickness and coronary artery disease risk factors.2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by represLipoprotein-associated phospholipase A2 and cardiovascular disease risk in HIV infection.The innate immune response in HIV/AIDS septic shock patients: a comparative study.Nutritionists' Health Study cohort: a web-based approach of life events, habits and health outcomesPrognostic Importance of C-Reactive Protein in High Cardiovascular Risk Patients With Type 2 Diabetes Mellitus: The Rio de Janeiro Type 2 Diabetes Cohort Study.Risk of death in heart disease is associated with elevated urinary globotriaosylceramide.Molecular diagnostics clinical utility strategy: a six-part framework.Weight-of-evidence evaluation of short-term ozone exposure and cardiovascular effects.Oxidized low-density lipoprotein as a biomarker of cardiovascular diseases.Review on cardiovascular risk prediction.Reassessing lipid metabolism and its potentialities in the prediction of cardiovascular risk.Technology platform development for targeted plasma metabolites in human heart failure.A urinary peptide biomarker set predicts worsening of albuminuria in type 2 diabetes mellitus.Ratios of leptin to insulin and adiponectin to endothelin are sex-dependently associated with extent of coronary atherosclerosis.The relationship of urotensin II with insulin resistance and hs-CRP in patients having PCOS.Comprehensive Metabolomic Profiling and Incident Cardiovascular Disease: A Systematic Review.No evidence of cardiovascular toxicity in workers exposed below 5 ppm carbon disulfide.Whole soy, but not purified daidzein, had a favorable effect on improvement of cardiovascular risks: a 6-month randomized, double-blind, and placebo-controlled trial in equol-producing postmenopausal women.High-sensitivity troponin T and C-reactive protein to identify patients without cardiac structural and functional abnormalities as assessed by cardiac CT and SPECT imaging: can biomarkers predict cardiac health?Branched Chain Amino Acids: Beyond Nutrition Metabolism.2016 European Guidelines on cardiovascular disease prevention in clinical practice
P2860
Q31164987-E55EC9B6-3F29-4FEC-B0FD-458504F3BAE2Q34046881-277FFEA7-E8F8-4E09-BCE8-11B371DEB3A8Q34214336-C49637D5-931D-456C-BA86-E3C9F2C7210CQ34850755-3A210C98-B9DC-4839-99A2-3CF13A33789BQ37236692-D924A40A-1CA7-4B84-B932-CFA21DE0060CQ37556069-4A47429D-FA75-41DE-A868-6C9D5DD5DD7AQ37648595-C5300439-6964-4101-A308-F71702E4A8FEQ38238592-AF6AD4D1-F37E-4607-823A-ECD883F0B50FQ38254523-DC2BEFA8-4CB5-4BC0-8D73-1B6027D4F161Q38299279-0E22E9C3-DA9E-4E51-B7D9-5179FBC3286FQ38373055-D9C0E6E8-453A-4C63-B72F-147068EA379EQ38494149-EC3373B6-7B9C-459B-89E2-473B5B3A5AF7Q43096198-3E0A92FB-A57E-415D-B761-D24705F9ECECQ44319128-C040A99B-61F3-4770-95F2-22A6CE7226E7Q45036053-8F7DC841-A14E-468F-B7B7-19A919CEC5BBQ46084798-F7FB1363-7FA0-4B07-ADC5-2EA736C45AC5Q47153055-FC6F5A64-1556-4537-AACB-1D4C8F48527FQ48861083-144FB788-D9D8-402E-9360-982935CE5ED8Q51330900-5AB5A837-9309-4E08-BFC0-76EED70283B9Q51840700-32779787-9F86-40AA-A2C9-73BF72E13BCFQ54981738-7715F334-2321-4777-9BB0-C8755A69B3F7Q56991525-D0FBDEF9-66F0-4FD1-BD23-4D66796B92F6
P2860
Biomarkers and cardiovascular risk assessment for primary prevention: an update.
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Biomarkers and cardiovascular risk assessment for primary prevention: an update.
@ast
Biomarkers and cardiovascular risk assessment for primary prevention: an update.
@en
type
label
Biomarkers and cardiovascular risk assessment for primary prevention: an update.
@ast
Biomarkers and cardiovascular risk assessment for primary prevention: an update.
@en
prefLabel
Biomarkers and cardiovascular risk assessment for primary prevention: an update.
@ast
Biomarkers and cardiovascular risk assessment for primary prevention: an update.
@en
P2860
P1433
P1476
Biomarkers and cardiovascular risk assessment for primary prevention: an update.
@en
P2093
Lauren G Gilstrap
Thomas J Wang
P2860
P356
10.1373/CLINCHEM.2011.165712
P407
P577
2011-11-28T00:00:00Z